BlackBoxRX
 
We highly recommend enabling Javascript while using the BlackBoxRX site.

Obiltoxaximab

Hypersensitivity and Anaphylaxis

  • Hypersensitivity reactions, including anaphylaxis, have been reported during Infusion
  • ANTHIM should be administered in monitored settings by personnel trained and equipped to manage anaphylaxis
  • Stop ANTHIM infusion immediately and treat appropriately if hypersensitivity or anaphylaxis occurs

Patient Counseling Information

Package Inserts

Obiltoxaximab

Updated April 2016